Qitan Technology specializes in nanopore sequencing, a cutting-edge method that allows for the real-time sequencing of single-stranded nucleic acid molecules. This technology operates by driving individual nucleic acid strands through a nanoscale protein pore, where variations in ionic current are measured to identify the sequence of bases. The company emphasizes several key technical advantages of its nanopore sequencing systems, including an integrated protein engineering platform for optimizing protein design, cost-effective biochips that require minimal sample amounts, and an innovative basecalling algorithm powered by artificial intelligence. These features collectively enhance the efficiency and accuracy of sequencing, making it suitable for a wide range of applications in microbial, human, animal, plant, and clinical research.

In addition to its advanced sequencing capabilities, Qitan Technology's nanopore sequencers are designed to be portable and user-friendly, allowing for on-site sequencing in various environments. This contrasts with traditional sequencing methods, which often require bulky equipment and extensive sample preparation. The nanopore technology not only simplifies the workflow by eliminating the need for PCR and complex library preparation but also reduces costs associated with sequencing runs. Overall, Qitan Technology's offerings represent a significant advancement in genomic research, providing researchers with the tools needed for efficient and flexible sequencing solutions.

China

Qitan Technology is a developer of genome sequencing technology, specializing in nanopore sequencing. The company has released datasets and publications related to its technology and has made significant technological achievements in the field of genetic code information.

T1-3101, Office Building, Raffles City, Chengdu, No. 3, Section 4, Renmin South Road, Wuhou District, Chengdu, Sichuan 610041

Qitan Technology

Company Details